Clovis Oncology Employee Directory
Biotechnology ResearchColorado, United States51-200 Employees
Clovis Oncology was a mid-sized biotechnology research company based in Boulder, Colorado. It focused on developing cancer therapies through collaborations, most notably Rubraca, a PARP inhibitor approved for ovarian and prostate cancer under a license with Pfizer. The organization is no longer in operation. The company has issued an important notice stating it is no longer operating and warning that messages about employment opportunities claiming to be from Clovis may be scams. Its work appeared to target patients and clinicians seeking new treatment options in cancer, with Rubraca representing a central program in its portfolio. The company has experienced notable leadership changes in 2026, including the departure of its chief medical officer and chief commercial officer, along with a significant workforce reduction in 2022.
1-888-653-2347 
support@leadiq.com 
